🇺🇸 FDA
Patent

US 8173135

Methods for preparing complex multivalent immunogenic conjugates

granted A61KA61K2039/6037A61K2039/62

Quick answer

US patent 8173135 (Methods for preparing complex multivalent immunogenic conjugates) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/6037, A61K2039/62, A61K39/116, A61K39/385